Suzanne George, Sebastian Bauer, Toshihiko Doi, Michael C. Heinrich, Lei Hua, Kirsten Leu, Natalia Ramos Hernandez, Albiruni Ryan Abdul Razak, Hank Schmidt, Lin Shen, Patrick Schöffski. "StrateGIST 3: A randomized, phase 3 study of velzatinib (IDRX-42) versus sunitinib in patients with advanced gastrointestinal stromal tumors after imatinib therapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps11588